rs2013040
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000894.3(LHB):c.*85C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0767 in 1,614,066 control chromosomes in the GnomAD database, including 5,190 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.079 ( 520 hom., cov: 33)
Exomes 𝑓: 0.076 ( 4670 hom. )
Consequence
LHB
NM_000894.3 3_prime_UTR
NM_000894.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0530
Genes affected
LHB (HGNC:6584): (luteinizing hormone subunit beta) This gene is a member of the glycoprotein hormone beta chain family and encodes the beta subunit of luteinizing hormone (LH). Glycoprotein hormones are heterodimers consisting of a common alpha subunit and an unique beta subunit which confers biological specificity. LH is expressed in the pituitary gland and promotes spermatogenesis and ovulation by stimulating the testes and ovaries to synthesize steroids. The genes for the beta chains of chorionic gonadotropin and for luteinizing hormone are contiguous on chromosome 19q13.3. Mutations in this gene are associated with hypogonadism which is characterized by infertility and pseudohermaphroditism. [provided by RefSeq, Jul 2008]
RUVBL2 (HGNC:10475): (RuvB like AAA ATPase 2) This gene encodes the second human homologue of the bacterial RuvB gene. Bacterial RuvB protein is a DNA helicase essential for homologous recombination and DNA double-strand break repair. Functional analysis showed that this gene product has both ATPase and DNA helicase activities. This gene is physically linked to the CGB/LHB gene cluster on chromosome 19q13.3, and is very close (55 nt) to the LHB gene, in the opposite orientation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 19-49015983-G-A is Benign according to our data. Variant chr19-49015983-G-A is described in ClinVar as [Benign]. Clinvar id is 1261028.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0829 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHB | NM_000894.3 | c.*85C>T | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000649238.3 | NP_000885.1 | ||
RUVBL2 | NM_006666.3 | c.*141G>A | downstream_gene_variant | ENST00000595090.6 | NP_006657.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0789 AC: 12003AN: 152170Hom.: 517 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
12003
AN:
152170
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0730 AC: 18334AN: 251226 AF XY: 0.0711 show subpopulations
GnomAD2 exomes
AF:
AC:
18334
AN:
251226
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0764 AC: 111749AN: 1461778Hom.: 4670 Cov.: 84 AF XY: 0.0757 AC XY: 55023AN XY: 727190 show subpopulations
GnomAD4 exome
AF:
AC:
111749
AN:
1461778
Hom.:
Cov.:
84
AF XY:
AC XY:
55023
AN XY:
727190
Gnomad4 AFR exome
AF:
AC:
2236
AN:
33478
Gnomad4 AMR exome
AF:
AC:
2041
AN:
44722
Gnomad4 ASJ exome
AF:
AC:
1588
AN:
26136
Gnomad4 EAS exome
AF:
AC:
2242
AN:
39700
Gnomad4 SAS exome
AF:
AC:
2415
AN:
86258
Gnomad4 FIN exome
AF:
AC:
7524
AN:
53406
Gnomad4 NFE exome
AF:
AC:
88584
AN:
1111928
Gnomad4 Remaining exome
AF:
AC:
4575
AN:
60390
Heterozygous variant carriers
0
6038
12077
18115
24154
30192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
3166
6332
9498
12664
15830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0790 AC: 12024AN: 152288Hom.: 520 Cov.: 33 AF XY: 0.0791 AC XY: 5889AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
12024
AN:
152288
Hom.:
Cov.:
33
AF XY:
AC XY:
5889
AN XY:
74448
Gnomad4 AFR
AF:
AC:
0.0662848
AN:
0.0662848
Gnomad4 AMR
AF:
AC:
0.0691413
AN:
0.0691413
Gnomad4 ASJ
AF:
AC:
0.0659942
AN:
0.0659942
Gnomad4 EAS
AF:
AC:
0.0561559
AN:
0.0561559
Gnomad4 SAS
AF:
AC:
0.0267081
AN:
0.0267081
Gnomad4 FIN
AF:
AC:
0.139397
AN:
0.139397
Gnomad4 NFE
AF:
AC:
0.0846882
AN:
0.0846882
Gnomad4 OTH
AF:
AC:
0.0874291
AN:
0.0874291
Heterozygous variant carriers
0
569
1138
1708
2277
2846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
218
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at